Anxiety: The Physiological Drivers
Anxiety is most commonly treated as a psychological condition requiring medication or psychotherapy. But for a significant proportion of people with anxiety, the primary driver is physiological: cortisol dysregulation, thyroid dysfunction, progesterone deficiency, reactive hypoglycemia, magnesium insufficiency, or gut dysbiosis driven neurochemical imbalance. Treating the physiology directly, rather than suppressing the symptoms pharmacologically, produces resolution that medication cannot achieve and eliminates the need for medications that address only the symptom.
Condition: Anxiety Physiology | Category: Neurological and Cognitive Health | Reviewed by: Brian Lamkin, DO
Anxiety is not a psychological weakness or a character trait. It is a measurable physiological state driven by identifiable biological mechanisms including HPA axis dysregulation, gut dysbiosis reducing GABA precursor availability, thyroid dysfunction producing sympathetic hyperactivation, histamine excess from MCAS activating brain histamine receptors, and blood sugar instability triggering catecholamine surges. Treating the mechanism rather than the symptom produces fundamentally different outcomes.
What Is Anxiety Physiology?
Anxiety at the physiological level is the activation of the sympathetic nervous system and HPA axis in response to perceived threat, producing the cascade of cortisol, adrenaline, and noradrenaline that prepares the body for fight-or-flight. In appropriate circumstances, this is adaptive and protective. Pathological anxiety arises when this system is chronically activated by physiological drivers that maintain sympathetic tone independent of actual psychological threat, or when the neurological braking mechanisms (GABA, vagal tone, prefrontal inhibition) that should terminate anxiety are impaired.
Functional medicine frames anxiety as a symptom with upstream biological causes rather than a primary disorder requiring symptom suppression. The same anxiety presentation can arise from cortisol insufficiency producing sympathetic compensation, from gut dysbiosis reducing serotonin and GABA precursor availability, from histamine excess activating brain histamine-1 receptors, from thyroid excess producing catecholamine-like sympathetic activation, or from blood sugar instability triggering counter-regulatory catecholamine surges. Each mechanism requires a different intervention.
Why It Matters
Anxiety physiology is one of the most consequential and most misunderstood presentations in functional medicine. Because anxiety has both neurological and physiological roots, treating it without evaluating the biological drivers produces partial and unsustained results.
- Disrupted sleep and fatigue: chronic anxiety activates the HPA axis and suppresses restorative sleep, compounding neurological vulnerability and creating a self-reinforcing cycle of dysregulation
- Cardiovascular strain: sustained sympathetic activation elevates heart rate, blood pressure, and inflammatory cytokines, increasing long-term cardiovascular risk independently of conventional risk factors
- Hormonal disruption: cortisol excess from chronic anxiety suppresses sex hormone production, thyroid function, and growth hormone pulsatility, producing fatigue, weight changes, and hormonal symptoms that are treated as separate issues
- Cognitive impairment: chronic HPA activation reduces hippocampal volume, impairs memory consolidation, and disrupts executive function, producing brain fog that is frequently misattributed to depression or aging
- Nutrient depletion: anxiety-driven cortisol elevation depletes magnesium, zinc, B vitamins, and GABA precursors that are required for neurological regulation, worsening the very anxiety driving the depletion
Anxiety physiology is treatable at its root. Identifying the dominant biological drivers and addressing them directly produces results that symptomatic medication alone consistently fails to achieve.
Common Symptoms
Neurological and Cognitive
- Excessive and persistent worry disproportionate to the situation producing functional impairment
- Racing thoughts, rumination, and inability to disengage from threat-focused thinking from prefrontal inhibitory circuit dysregulation
- Hypervigilance and exaggerated startle response from sympathetic nervous system hyperactivation maintaining threat-detection mode
- Difficulty concentrating and cognitive impairment from the prefrontal cortex resources diverted by sustained anxiety activation
- Sleep onset difficulty from the cortisol and catecholamine elevation that delays the transition to sleep and disrupts sleep architecture
Physical and Autonomic
- Palpitations and heart rate elevation from sympathetic cardiac activation that may be indistinguishable from POTS or thyroid-driven tachycardia
- Muscle tension, jaw clenching, and physical restlessness from sustained sympathetic tone maintaining muscle readiness
- Shortness of breath and chest tightness from the hyperventilation that accompanies sympathetic activation
- Gastrointestinal symptoms including nausea, diarrhea, and cramping from the autonomic nervous system effects on gut motility during anxiety activation
- Sweating, tremor, and temperature fluctuation from autonomic dysregulation during anxiety episodes
Systemic Manifestations
- Fatigue from the metabolic cost of sustained HPA axis activation and the sleep disruption that chronic anxiety produces
- Blood sugar instability with post-meal anxiety surges from the adrenaline response to reactive hypoglycemia
- Allergic-type reactions and skin flushing from concurrent MCAS contributing histamine-driven anxiety symptoms
- Thyroid-like symptoms including heat intolerance and weight changes from the catecholamine effects of anxiety on metabolic rate
- Hormonal dysregulation from HPA axis cortisol burden impairing sex hormone production through shared biosynthetic precursors
Root Causes: A Functional Medicine Perspective
The gut-brain axis is one of the most mechanistically important contributors to anxiety physiology. Gut dysbiosis reduces the production of tryptophan available for serotonin synthesis; over 90% of the body's serotonin is produced in the gut. Dysbiosis also reduces the availability of glutamate precursors for GABA synthesis, impairing the primary inhibitory neurotransmitter that suppresses anxiety circuits. The vagal nerve carries the gut-brain signal bidirectionally; poor vagal tone reduces the parasympathetic brake on anxiety and reduces the enteric serotonin signal reaching the brain.
Blood sugar instability is one of the most consistently underappreciated anxiety drivers. Reactive hypoglycemia triggers adrenaline and cortisol release that produces the sweating, heart pounding, and panic that patients and clinicians alike attribute to anxiety disorder. The episodes predictably follow carbohydrate intake by 1-2 hours and resolve with glucose intake, a pattern that distinguishes it from true psychological anxiety but is rarely systematically elicited from the history.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Evaluation framework | DSM symptom cluster classification; biological investigation not standard; thyroid function sometimes checked | Systematic evaluation of HPA axis status, gut microbiome, thyroid function, histamine burden, blood sugar stability, and nutrient cofactors for neurotransmitter synthesis |
| Blood sugar assessment | Not evaluated in anxiety workup; fasting glucose and HbA1c occasionally checked but postprandial patterns not assessed | Fasting insulin, postprandial glucose pattern, and dietary history evaluated; CGM considered when reactive hypoglycemia is clinically suspected as anxiety driver |
| Gut assessment | Not evaluated in psychiatric workup despite gut dysbiosis directly impairing GABA and serotonin precursor availability | Comprehensive gut evaluation including microbiome, intestinal permeability, SIBO, and H. pylori as modifiable anxiety drivers |
| Pharmaceutical approach | SSRIs as first-line; benzodiazepines for acute management; neither addresses the biological mechanism | Mechanism-targeted interventions first; magnesium for GABA support; L-theanine for glutamatergic calming; gut treatment; blood sugar stabilization; SSRIs as adjuncts when physiological mechanisms do not fully resolve symptoms |
| Thyroid evaluation | TSH occasionally checked; subclinical thyroid abnormalities producing sympathetic hyperactivation frequently missed | Full thyroid panel including free T3, free T4, reverse T3, and TPO antibodies; subclinical hyperthyroidism and Hashimoto's thyrotoxicosis as common anxiety drivers requiring specific intervention |
Key Labs to Evaluate
A complete evaluation of this condition requires characterizing both the primary mechanism and the upstream hormonal, metabolic, and inflammatory context driving it.
Neurological and Adrenal
Metabolic and Inflammatory
How to Interpret These Labs Together
Individual lab values have limited sensitivity for this condition in isolation. The diagnostic signal comes from recognizing patterns across multiple markers simultaneously.
The patterns below represent the most clinically informative marker combinations. Interpreting these together rather than in isolation is what separates functional medicine evaluation from standard lab review.
| Pattern | What It Means |
|---|---|
| Elevated evening cortisol with low morning cortisol and fatigue | Burned-out HPA pattern: morning low drive, evening hyperactivation producing insomnia and anxiety. Adrenal support and evening cortisol modulation are first-line. |
| Elevated cortisol across all time points with elevated hs-CRP | Sustained stress response with systemic inflammation. Both drivers require simultaneous intervention. |
| Low DHEA-S with high cortisol-to-DHEA ratio | Cortisol dominance from adrenal androgen depletion amplifying anxiety physiology. DHEA repletion shifts the ratio and reduces cortisol-driven neurological hyperreactivity. |
| Low RBC magnesium with poor sleep and heightened startle response | Magnesium deficiency as a primary neurological driver. Magnesium glycinate repletion frequently produces rapid improvement in anxiety, sleep, and hyperreactivity. |
Common Patterns Seen in Patients
- The patient with panic attacks 90 minutes after eating who is told they have panic disorder: predictable episodes of racing heart, sweating, and dread occurring 90-120 minutes after carbohydrate-containing meals; fasting insulin of 18 uIU/mL confirms insulin resistance with reactive hypoglycemia; adrenaline response to postprandial glucose crash is producing panic physiology; dietary carbohydrate reduction eliminates episodes within 2 weeks without any anxiolytic
- The woman with anxiety from Hashimoto's thyrotoxicosis never assessed: anxiety and palpitations for 3 years; TSH of 1.2 mIU/L declared normal; TPO antibodies of 890 IU/mL indicating Hashimoto's with thyrotoxic phase; free T3 in the upper quartile of range; thyroid antibody management and selenium supplementation stabilize thyroid function and resolve the anxiety that SSRI could not address
- The patient with MCAS-driven anxiety never identified: episodes of racing heart, flushing, and panic without identifiable psychological trigger; consistent association with specific foods, heat, and exercise; H1 and H2 antihistamine trial produces dramatic reduction in anxiety episode frequency; histamine excess from MCAS was activating brain histamine receptors to produce the anxiety physiology
- The anxiety patient who improves on gut treatment: severe generalized anxiety alongside IBS; SIBO confirmed on lactulose breath test; rifaximin treatment produces significant gut symptom improvement; anxiety severity reduces by 50% concurrently as gut dysbiosis driving neuroinflammation and GABA precursor depletion is resolved; the psychiatric medication that provided partial improvement is reduced without worsening
Treatment and Optimization Strategy
Nutritional Foundation
Magnesium glycinate at 400 to 600 mg nightly is the highest-yield single nutritional intervention for anxiety physiology, directly supporting GABA receptor function and HPA axis regulation. Zinc, vitamin B6, and B12 repleted to optimal ranges restore GABA synthesis capacity. Eliminating refined carbohydrates and stabilizing blood sugar removes the reactive hypoglycemia-driven adrenaline spikes that are frequently misidentified as anxiety attacks.
Lifestyle and HPA Axis Regulation
Sleep optimization is the most powerful HPA axis reset available: seven to nine hours of quality sleep reduces morning cortisol within days of consistent implementation. Resistance training three to four times per week reduces basal cortisol and increases GABA receptor sensitivity. Breath-based parasympathetic activation through diaphragmatic breathing and HRV biofeedback produces measurable cortisol reduction within minutes and trains long-term vagal tone improvement.
Targeted Clinical Interventions
Adaptogenic botanicals including ashwagandha, rhodiola, and phosphatidylserine modulate HPA axis reactivity through cortisol receptor and feedback mechanisms with randomized trial support. L-theanine at 200 to 400 mg promotes alpha wave activity and reduces cortisol without sedation. When thyroid dysfunction, PCOS, or perimenopause are identified as contributors, addressing those upstream drivers frequently resolves anxiety that had resisted every other intervention.
What Most Doctors Miss
- Blood sugar instability as an anxiety driver is almost never evaluated: reactive hypoglycemia from insulin resistance or dietary carbohydrate excess produces adrenaline and cortisol surges that are physiologically identical to panic attacks and clinically indistinguishable from anxiety disorder; fasting insulin and postprandial glucose pattern are never checked in a standard anxiety workup despite this mechanism being common and entirely correctable through dietary intervention
- Thyroid function beyond TSH is not evaluated: TSH within range does not exclude subclinical hyperthyroidism from T3 excess or Hashimoto's thyrotoxicosis; both produce catecholamine receptor sensitization and sympathetic hyperactivation that generates anxiety physiology; free T3, free T4, and TPO antibodies are essential components of anxiety evaluation that are essentially never ordered from a psychiatric consultation
- Magnesium deficiency as the most common correctable anxiety contributor is not tested: magnesium is required for GABA receptor function, NMDA receptor regulation, and HPA axis cortisol termination; its deficiency directly lowers the anxiety threshold through three simultaneous mechanisms; RBC magnesium is deficient in a significant proportion of the general population and is almost never assessed in anxiety evaluation
- MCAS as a driver of anxiety physiology is outside the standard psychiatric framework: histamine directly activates brain H1 receptors producing anxiety, racing thoughts, and hypervigilance; prostaglandins produce cardiovascular symptoms that compound the anxiety; MCAS is not evaluated in psychiatric practice despite being present in a meaningful proportion of patients with treatment-resistant anxiety
When to Seek Medical Care
Seek biological evaluation for anxiety if you experience anxiety that has not responded to first-line psychological and pharmacological treatment, anxiety with a consistent physiological pattern (post-meal timing, allergic-type reactions, specific triggers), anxiety accompanied by physical symptoms including palpitations, heat intolerance, or gastrointestinal symptoms, or anxiety that emerged or worsened after a physical illness or period of significant stress. These patterns suggest a biological contributor requiring identification and targeted treatment.
Seek prompt evaluation if you experience episodes that include severe palpitations, chest pain, difficulty breathing, or loss of consciousness, as these require cardiac and thyroid evaluation before a purely psychological anxiety diagnosis is accepted.
Recommended Testing
Identifying the root cause of this condition requires going beyond standard labs. The following markers provide the most clinically useful insights.
Foundational Labs
- Cortisol (4-point salivary)
- Free T3 and Free T4
- Fasting Insulin / HOMA-IR
- Magnesium (RBC)
- hs-CRP
Advanced Assessment
- TPO Antibodies
- Serum Tryptase
- Comprehensive Stool Analysis
- SIBO Breath Test
- Plasma Homocysteine (methylation assessment)
Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Is anxiety always psychological?
No. Anxiety is a physiological state that can be driven by identifiable biological mechanisms including HPA axis dysregulation, thyroid dysfunction, gut dysbiosis reducing GABA precursor availability, histamine excess from MCAS, blood sugar instability triggering adrenaline surges, and magnesium deficiency impairing GABA receptor function. These biological drivers produce anxiety that is physiologically indistinguishable from psychologically driven anxiety but responds to biological rather than psychological treatment.
Can diet cause anxiety?
Yes. Blood sugar instability from refined carbohydrate excess produces reactive hypoglycemia that triggers adrenaline and cortisol surges producing anxiety and panic-like episodes. Histamine-containing foods trigger MCAS reactions in susceptible individuals producing brain histamine receptor activation and anxiety symptoms. Gut dysbiosis from poor dietary patterns reduces GABA and serotonin precursor availability. Each mechanism links dietary patterns directly to anxiety physiology.
Does magnesium help anxiety?
Yes, through multiple mechanisms. Magnesium is required for GABA receptor function; its deficiency impairs the primary inhibitory neurotransmitter system that suppresses anxiety circuits. Magnesium also regulates NMDA glutamate receptors, preventing excessive excitatory signaling that drives anxiety. HPA axis cortisol termination requires magnesium; its deficiency prolongs the cortisol response to stressors. RBC magnesium should be tested before and after supplementation.
Can gut health affect anxiety?
Yes. Over 90% of serotonin is produced in the gut; gut dysbiosis reduces tryptophan availability for serotonin synthesis. Gut dysbiosis also impairs GABA precursor availability, produces neuroinflammatory cytokines that cross the blood-brain barrier, and reduces vagal tone that normally suppresses anxiety circuits. Clinical trials demonstrate that specific probiotic strains produce measurable anxiolytic effects equivalent to some pharmaceutical interventions.
When should I consider medication for anxiety?
Medication is appropriate when biological drivers have been identified and addressed and anxiety remains significantly impairing, or when anxiety severity is sufficient to prevent the engagement with biological evaluation and treatment. Medication works best as an adjunct to biological correction rather than a replacement for it. SSRIs and SNRIs have evidence for anxiety management; benzodiazepines produce physiological dependence and should be used short-term only.
How The Lamkin Clinic Approaches Anxiety
When I see a patient with anxiety, my first question is what is driving the nervous system into this state of activation, not what medication will suppress the symptom. Blood sugar instability, thyroid dysfunction, gut dysbiosis, MCAS, and HPA axis dysregulation are all identifiable, measurable, and correctable. When we identify the mechanism and address it directly, many patients experience resolution of anxiety they have been managing with medications for years. That is a fundamentally different outcome than symptom suppression. - Brian Lamkin, DO
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, anxiety evaluation begins with cortisol rhythm assessment, full thyroid panel including antibodies, fasting insulin and blood sugar pattern evaluation, gut microbiome assessment, and magnesium status. We do not assume the anxiety is psychologically driven until biological contributors have been systematically excluded and treated. Medication may be part of the protocol, but it is informed by the biological picture rather than applied as a default first step.
